Radiolabeled antibodies for therapy of infectious diseases

Ekaterina Dadachova, Arturo Casadevall

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There is a growing need for alternatives to conventional antibiotics for the treatment of infectious diseases. The number of bacterial pathogens that are resistant even to the most powerful antibiotics is growing each year. HIV remains an incurable disease more than 30 years since its identification. Since 1979 there has been a >200% increase in the annual number of cases of invasive fungal infections in the United States. To exacerbate these problems, the number of patients who cannot fight infections because of impaired immunity is growing and includes HIV patients, patients who have been through cancer chemotherapy, and organ transplant recipients.

Original languageEnglish (US)
Title of host publicationAntibodies for Infectious Diseases
Publisherwiley
Pages399-409
Number of pages11
ISBN (Electronic)9781683670988
ISBN (Print)9781555817350
DOIs
StatePublished - May 26 2015

Keywords

  • Bacterial infection
  • Fungal infection
  • HAART
  • Human immunodeficiency virus
  • Radioimmunotherapy
  • Radiolabeled antibody

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Radiolabeled antibodies for therapy of infectious diseases'. Together they form a unique fingerprint.

Cite this